BiOptix Participates in Leading Life Sciences Event BioWest 2012
BOULDER, Colo., September 11, 2012 /PRNewswire/ -- BiOptix announced continued support of the Colorado BioScience Association today, with participation in BioWest 2012, a leading life sciences showcase event in Colorado to be held at the Denver Marriott City Center.
"BiOptix continues to believe in the goals and community that is fostered by the Colorado BioScience Association, noted Rick Whitcomb, President and CEO of BiOptix. "As Colorado continues to expand its footprint in the biosciences, BiOptix is proud to be an important part of that growth story, noted Whitcomb.
At BioWest 2012, BiOptix will highlight the upcoming 404pi, one of the most anticipated product launches in the SPR (Surface Plasmon Resonance) space. "We are excited to launch the BiOptix 404pi, and feel that this Enhanced SPR instrument provides exceptional value and changes the game," noted Ken Wilczek, Vice President of Sales and Marketing for BiOptix. "We have significant and building interest in the 404pi," continued Wilczek.
Features of the BiOptix 404pi include:
- Enhanced SPR for high sensitivity
- 4 injector / 4 flow cell design for high-throughput
- Advanced automated fluidic system for fast kinetic measurements
- Multiple surface chemistries
- Compatible with industry standard Scrubber 2 software
- Cost-effective and simple to operate
Surface Plasmon Resonance is an advanced and highly sensitive optical technology that can measure refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.
BiOptix Diagnostics Corporation, a privately held firm based in Boulder, Colorado has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements.
Additional information about BiOptix and our products can be found at: www.bioptix.com